Skip to main
AFL

Aflac (AFL) Stock Forecast & Price Target

Aflac (AFL) Analyst Ratings

Based on 13 analyst ratings
Hold
Strong Buy 0%
Buy 15%
Hold 54%
Sell 31%
Strong Sell 0%

Bulls say

Aflac is well-positioned for future growth with its expanding product offerings and a plan to increase the ceding rate of Japanese liabilities, freeing up capital for investment. The company has faced challenges with earnings emergence and a consistently high benefit ratio, but they remain confident in their outlook and are focused on maintaining profitability. The recent restructuring of their investment income portfolio and growth in premiums are positive indicators for the company's financial performance.

Bears say

Aflac is facing challenges in both its medical insurance product sales and its potential mergers and acquisitions. With a decline in sales in the second quarter due to product launch timing and a less aggressive sales campaign, and the need for careful evaluation of potential acquisitions, the company's financial outlook remains uncertain. Despite strong earnings, structural changes are needed to increase shareholder returns and support future business growth.

Aflac (AFL) has been analyzed by 13 analysts, with a consensus rating of Hold. 0% of analysts recommend a Strong Buy, 15% recommend Buy, 54% suggest Holding, 31% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Aflac and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Aflac (AFL) Forecast

Analysts have given Aflac (AFL) a Hold based on their latest research and market trends.

According to 13 analysts, Aflac (AFL) has a Hold consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $115.85, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $115.85, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Aflac (AFL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.